Financial News

Nutrien Reports Second Quarter 2026 Results

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

First half results demonstrate continued operational excellence and strong financial performance

Raised Potash sales volumes and lowered capital expenditures guidance ranges

Increased cash returns to shareholders

All amounts are in US dollars, except as otherwise noted

Nutrien Ltd. (TSX and NYSE: NTR) announced today its second quarter 2026 results, with net earnings of $1.22 billion ($2.53 diluted net earnings per share). Second quarter 2026 adjusted EBITDA1 was $2.43 billion and adjusted net earnings per share1 was $2.61.

“In the first half of 2026, Nutrien delivered record potash sales volumes, strong growth in proprietary products margins and further enhanced the reliability and cost position of our nitrogen assets in a dynamic global operating environment,” commented Ken Seitz, Nutrien’s President and CEO. “Our focus on operational excellence, targeted growth investments and ongoing portfolio optimization initiatives is strengthening our business, supporting structural free cash flow growth and increasing cash returns to shareholders.”

Highlights2:

  • Retail adjusted EBITDA increased to $1.24 billion in the first half of 2026 due to higher proprietary products gross margins and a strong livestock market in Australia, partially offset by lower crop nutrient sales volumes and higher fuel costs.
  • Potash adjusted EBITDA increased to $1.24 billion in the first half of 2026 due to higher global benchmarks and strong operational and supply chain execution that supported record first half sales volumes. We had record potash production and progressed mine automation, maintaining our controllable cash cost of product manufactured1 below $60 per tonne.
  • Nitrogen adjusted EBITDA increased to $1.12 billion in the first half of 2026 due to higher global nitrogen benchmarks and lower natural gas costs. Production from our low-cost North American nitrogen plants was consistent with our plan, which included the successful execution of the largest turnaround in our Carseland facility’s history.
  • Cash provided by operating activities increased by 12 percent in the first half of 2026. We returned $848 million to shareholders in the first half of 2026 through dividends and share repurchases, including a 26 percent increase in share repurchases. We further increased the pace of share repurchases in the third quarter of 2026 and repurchased approximately $82 million of common shares in the quarter as of August 4, 2026.
  • Since June 2026, we entered into agreements to sell non-core assets for expected gross proceeds of approximately $90 million. Including these agreements, we have divested approximately $1 billion of non-core assets since the fourth quarter of 2024.
  • Remain on track to solidify the optimal path for our Phosphate business, Trinidad Nitrogen facility and Brazilian Retail business in 2026.
1 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section. All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted.
2 Our discussion of highlights set out on this page is a comparison of the results for the six months ended June 30, 2026 to the results for the six months ended June 30, 2025, unless otherwise noted.
 

Management’s Discussion and Analysis

The following management’s discussion and analysis (“MD&A”) is the responsibility of management and is dated as of August 5, 2026. The Board of Directors (“Board”) of Nutrien carries out its responsibility for review of this disclosure principally through its Audit Committee, composed entirely of independent directors. The Audit Committee reviews and, prior to its publication, approves this disclosure pursuant to the authority delegated to it by the Board. The term “Nutrien” refers to Nutrien Ltd. and the terms “we”, “us”, “our”, “Nutrien” and “the Company” refer to Nutrien and, as applicable, Nutrien and its direct and indirect subsidiaries on a consolidated basis. Additional information relating to Nutrien (which, except as otherwise noted, is not incorporated by reference herein), including our annual report dated February 19, 2026 (“2025 Annual Report”), which includes our annual audited consolidated financial statements (“annual financial statements”) and MD&A, and our annual information form dated February 19, 2026, each for the year ended December 31, 2025, can be found on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. No update is provided to the disclosure in our 2025 annual MD&A except for material information since the date of our annual MD&A. The Company is a foreign private issuer under the rules and regulations of the US Securities and Exchange Commission (the “SEC”).

This MD&A is based on, and should be read in conjunction with, the Company’s unaudited interim condensed consolidated financial statements as at and for the three and six months ended June 30, 2026 (“interim financial statements”) based on International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board and prepared in accordance with International Accounting Standard (“IAS”) 34 “Interim Financial Reporting”, unless otherwise noted. This MD&A contains certain non-GAAP financial measures and ratios and forward-looking statements, which are described in the “Non-GAAP Financial Measures” and the “Forward-Looking Statements” sections, respectively.



Market Outlook and Guidance

Agriculture and Retail Markets

  • Global agricultural markets are supported by robust grain and oilseed demand. Risks to global crop production and trade have increased due to geopolitical uncertainty and forecasts indicating El Niño conditions, which are expected to place upside pressure on crop prices.
  • In North America, firming crop prices and a focus on protecting yield potential is expected to support crop input demand in the third quarter of 2026. A faster than average pace of crop development supports the potential for an earlier start to the fall fertilizer application season.
  • In Australia, grower engagement across key cropping regions and strong livestock economics are supporting demand for retail products and services. In Brazil, soybean acreage is expected to moderately increase from the prior year and purchasing activity continues to be influenced by credit availability and affordability.

Crop Nutrient Markets

  • Global potash markets remain constructive due to favorable affordability, healthy demand in all major global markets and stable supply relative to other commodities. We have maintained our forecast for global potash shipments of 74 to 77 million tonnes in 2026 as projected shipment levels are expected to be consistent with consumption.
  • Global urea prices have strengthened in the third quarter of 2026 following a decline in the latter half of the second quarter during a seasonal low point for demand that was exacerbated this year due to evolving geopolitical developments. Global nitrogen market fundamentals are expected to remain tight in the second half of 2026, driven by ongoing trade flow disruptions, production outages, elevated energy prices and import demand from key consuming regions such as India and Brazil.
  • Global phosphate market fundamentals continue to be affected by trade flow disruptions, constrained sulfur feedstock availability and elevated costs, which have placed unsustainable pressure on phosphate producer margins and have resulted in reduced global operating rates.

Financial and Operational Guidance

  • Retail adjusted EBITDA guidance of $1.75 to $1.95 billion represents structural growth in our downstream business consistent with historical rates. The mid-point of our full-year guidance range assumes high-single digit growth in proprietary products gross margins, strong demand for crop inputs and services in Australia, increased crop nutrient margins per tonne and lower crop nutrient sales volumes compared to the prior year.
  • Potash sales volume guidance was increased to 14.2 to 14.8 million tonnes due to strong demand in key offshore markets and is consistent with our global shipment expectation.
  • Nitrogen sales volume guidance of 9.2 to 9.7 million tonnes is supported by planned reliability improvements and debottlenecking initiatives. The range reflects the completion of planned turnarounds in the third quarter of 2026 and higher ammonia operating rates in the fourth quarter compared to the prior year.
  • Phosphate sales volume guidance of 2.4 to 2.6 million tonnes reflects the benefits of reliability improvement initiatives completed in 2025.
  • Total capital expenditures guidance was lowered to $1.95 to $2.05 billion and reflects a focus on capital efficiency and structurally growing free cash flow.

All guidance expectations, including those noted above, are outlined in the table below. Refer to page 33 of our 2025 Annual Report for anticipated fertilizer pricing and natural gas price sensitivities relating to adjusted EBITDA (consolidated) and adjusted net earnings per share.

 

2026 Guidance Ranges1 as of

 

August 5, 2026

 

May 6, 2026

($ billions, except as otherwise noted)

Low

 

High

 

Low

 

High

Retail adjusted EBITDA

1.75

 

1.95

 

1.75

 

1.95

Potash sales volumes (million tonnes)2

14.2

 

14.8

 

14.1

 

14.8

Nitrogen sales volumes (million tonnes)2

9.2

 

9.7

 

9.2

 

9.7

Phosphate sales volumes (million tonnes)2

2.4

 

2.6

 

2.4

 

2.6

Depreciation and amortization

2.4

 

2.5

 

2.4

 

2.5

Finance costs

0.65

 

0.75

 

0.65

 

0.75

Effective tax rate on adjusted net earnings (%)3

24.0

 

26.0

 

24.0

 

26.0

Capital expenditures4

1.95

 

2.05

 

2.0

 

2.1

1 See the “Forward-Looking Statements” section.

2 Manufactured product only.

3 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

4 Comprised of sustaining capital expenditures, investing capital expenditures and mine development and pre-stripping capital expenditures, which are supplementary financial measures. See the “Other Financial Measures” section.

Consolidated Results

 

Three Months Ended June 30

 

Six Months Ended June 30

 

($ millions, except as otherwise noted)

2026

 

2025

 

% Change

 

2026

 

2025

 

% Change

Sales

10,812

 

10,438

 

4

 

16,858

 

15,538

 

8

Gross margin

3,251

 

3,175

 

2

 

4,897

 

4,495

 

9

Expenses

1,474

 

1,393

 

6

 

2,760

 

2,487

 

11

Net earnings

1,222

 

1,229

 

(1)

 

1,361

 

1,248

 

9

Adjusted EBITDA1

2,430

 

2,486

 

(2)

 

3,535

 

3,338

 

6

Diluted net earnings per share (dollars)2

2.53

 

2.50

 

1

 

2.80

 

2.52

 

11

Adjusted net earnings per share (dollars)1, 2

2.61

 

2.65

 

(2)

 

3.11

 

2.75

 

13

1 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

2 All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted.

Net earnings and adjusted EBITDA increased in the first half of 2026, primarily due to increased global fertilizer benchmarks, higher Retail earnings and record Potash sales volumes. Net earnings and adjusted EBITDA decreased in the second quarter of 2026, as higher global fertilizer benchmarks were more than offset by lower fertilizer volumes and increased sulfur costs.



Segment Results

Our discussion of segment results set out on the following pages is a comparison of the results for the three and six months ended June 30, 2026 to the results for the three and six months ended June 30, 2025, unless otherwise noted.

Retail

 

Three Months Ended June 30

 

Six Months Ended June 30

($ millions, except as otherwise noted)

2026

 

 

2025

 

% Change

 

2026

 

 

2025

 

% Change

Sales

8,270

 

7,959

 

4

 

11,910

 

11,049

 

8

Cost of goods sold

6,224

 

5,941

 

5

 

9,064

 

8,345

 

9

Gross margin

2,046

 

2,018

 

1

 

2,846

 

2,704

 

5

Adjusted EBITDA1

1,131

 

1,149

 

(2)

 

1,239

 

1,195

 

4

1 See Note 2 to the interim financial statements.

  • Retail adjusted EBITDA increased in the first half of 2026 due to higher proprietary products gross margins and a strong livestock market in Australia. Retail adjusted EBITDA decreased in the second quarter of 2026 mainly due to lower crop nutrient sales volumes and higher fuel costs.

 

Three Months Ended June 30

 

Six Months Ended June 30

 

Sales

 

Gross Margin

 

Sales

 

Gross Margin

($ millions)

2026

 

2025

 

2026

 

2025

 

2026

 

2025

 

2026

 

2025

Crop nutrients

3,541

 

3,391

 

695

 

697

 

5,024

 

4,585

 

945

 

916

Crop protection products

2,755

 

2,666

 

707

 

676

 

3,892

 

3,638

 

933

 

867

Seed

1,278

 

1,278

 

242

 

266

 

1,840

 

1,810

 

326

 

336

Services and other

308

 

286

 

256

 

235

 

483

 

432

 

400

 

353

Merchandise

291

 

238

 

49

 

44

 

514

 

427

 

85

 

75

Nutrien Financial

145

 

135

 

145

 

135

 

225

 

205

 

225

 

205

Nutrien Financial elimination1

(48)

 

(35)

 

(48)

 

(35)

 

(68)

 

(48)

 

(68)

 

(48)

Total

8,270

 

7,959

 

2,046

 

2,018

 

11,910

 

11,049

 

2,846

 

2,704

1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

  • Crop nutrients sales increased in the second quarter and first half of 2026 due to higher selling prices. Gross margin was relatively flat in the second quarter of 2026, as increased sales of proprietary nutritional products was offset by lower crop nutrient sales volumes, in particular phosphate and nitrogen products. Gross margin increased in the first half of 2026, reflecting increased sales of proprietary nutritional products.

  • Crop protection products sales and gross margin increased in the second quarter and first half of 2026 due to higher sales of proprietary products, supported by increased herbicide sales volumes in the US and earlier grower engagement in Australia.

  • Seed gross margin decreased in the second quarter and first half of 2026 primarily due to product mix shifts, partially offset by higher sales volumes, including higher-margin canola seed in Australia.

  • Services and other sales and gross margin increased in the second quarter and first half of 2026 due to a strong livestock market in Australia.

Supplemental Data

Three Months Ended June 30

 

Six Months Ended June 30

 

Gross Margin

 

% of Product Line1

 

Gross Margin

 

% of Product Line1

($ millions, except as otherwise noted)

2026

 

2025

 

2026

 

2025

 

2026

 

2025

 

2026

 

2025

Proprietary products

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Crop nutrients

248

 

228

 

36

 

33

 

328

 

297

 

35

 

32

Crop protection products

314

 

246

 

45

 

37

 

402

 

299

 

43

 

34

Seed

86

 

87

 

35

 

37

 

107

 

115

 

33

 

34

Merchandise

4

 

3

 

8

 

6

 

6

 

6

 

7

 

7

Total

652

 

564

 

32

 

29

 

843

 

717

 

30

 

27

1 Represents percentage of proprietary product margins over total product line gross margin.

 

Three Months Ended June 30

 

Six Months Ended June 30

 

Sales Volumes

(tonnes – thousands)

 

Gross Margin / Tonne

(dollars)

 

Sales Volumes

(tonnes – thousands)

 

Gross Margin / Tonne

(dollars)

 

2026

 

2025

 

2026

 

2025

 

2026

 

2025

 

2026

 

2025

Crop nutrients

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America

3,795

 

4,419

 

167

 

146

 

5,395

 

5,883

 

156

 

142

International

1,057

 

1,072

 

58

 

48

 

1,905

 

1,898

 

54

 

42

Total

4,852

 

5,491

 

143

 

127

 

7,300

 

7,781

 

129

 

118

 

(percentages)

June 30, 2026

 

December 31, 2025

Financial performance measures1, 2

 

 

 

Cash operating coverage ratio

63

 

62

Average working capital to sales

23

 

22

1 Rolling four quarters.

2 These are non-GAAP financial measures. See the “Non-GAAP Financial Measures” section.

Potash

 

Three Months Ended June 30

 

Six Months Ended June 30

($ millions, except as otherwise noted)

2026

 

 

2025

% Change

 

2026

 

 

2025

% Change

Net sales

1,053

 

991

 

6

 

1,979

 

1,735

 

14

Cost of goods sold

446

 

440

 

1

 

868

 

820

 

6

Gross margin

607

 

551

 

10

 

1,111

 

915

 

21

Adjusted EBITDA1

658

 

630

 

4

 

1,236

 

1,076

 

15

1 See Note 2 to the interim financial statements.

  • Potash adjusted EBITDA increased in the second quarter and first half of 2026 due to higher global benchmarks and strong operational and supply chain execution that supported record first half sales volumes, partially offset by higher provincial mining taxes. We had record production and progressed mine automation, maintaining our controllable cash cost of product manufactured1 below $60 per tonne.

Manufactured Product

Three Months Ended
June 30

 

Six Months Ended
June 30

($ per tonne, except as otherwise noted)

2026

 

2025

 

2026

 

2025

Sales volumes (tonnes – thousands)

 

 

 

 

 

 

 

North America

922

 

1,038

 

2,207

 

2,350

Offshore

3,021

 

2,951

 

5,246

 

5,041

Total sales volumes

3,943

 

3,989

 

7,453

 

7,391

Net selling price

 

 

 

 

 

 

 

North America

295

 

279

 

290

 

259

Offshore

259

 

237

 

255

 

224

Average net selling price

267

 

248

 

266

 

235

Cost of goods sold

113

 

110

 

117

 

112

Gross margin

154

 

138

 

149

 

123

Depreciation and amortization

47

 

47

 

48

 

47

Gross margin excluding depreciation and amortization1

201

 

185

 

197

 

170

1 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

  • Sales volumes increased in the first half of 2026 due to low inventory levels and favorable potash affordability in key offshore markets.
  • Net selling price per tonne increased in the second quarter and first half of 2026 due to higher global benchmark prices, partially offset by higher offshore freight and insurance costs.
  • Cost of goods sold per tonne increased in the second quarter and first half of 2026 primarily due to higher royalties and maintenance costs.

Supplemental Data

Three Months Ended
June 30

 

Six Months Ended
June 30

 

2026

 

2025

 

2026

 

2025

Production volumes (tonnes – thousands)

3,996

 

3,531

 

7,656

 

6,820

Potash controllable cash cost of product manufactured per tonne1

55

 

55

 

57

 

57

Canpotex sales by market (percentage of sales volumes)2

 

 

 

 

 

 

 

Latin America

47

 

42

 

44

 

37

Other Asian markets3

23

 

34

 

26

 

33

China

11

 

8

 

14

 

12

India

4

 

 

3

 

2

Other markets

15

 

16

 

13

 

16

Total

100

 

100

 

100

 

100

1 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

2 See Note 8 to the interim financial statements.

3 All Asian markets except China and India.

Nitrogen

 

Three Months Ended June 30

 

Six Months Ended June 30

($ millions, except as otherwise noted)

2026

 

 

20251, 2

% Change

 

2026

 

 

20251, 2

% Change

Net sales

1,154

 

1,187

 

(3)

 

2,168

 

2,072

 

5

Cost of goods sold

611

 

674

 

(9)

 

1,258

 

1,272

 

(1)

Gross margin

543

 

513

 

6

 

910

 

800

 

14

Adjusted EBITDA2

635

 

665

 

(5)

 

1,117

 

1,070

 

4

1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

2 See Note 2 to the interim financial statements.

  • Nitrogen adjusted EBITDA increased in the first half of 2026 due to higher global nitrogen benchmarks and lower natural gas costs. Production from our low-cost North American nitrogen plants was consistent with our plan, which included the successful execution of the largest turnaround in our Carseland facility’s history. Nitrogen adjusted EBITDA decreased in the second quarter of 2026 due to lower sales volumes, partially offset by higher global benchmarks. Other expenses increased in the second quarter and first half of 2026 due to Trinidad safe mode costs incurred in connection with its controlled shutdown and the absence of Profertil equity earnings recognized in the comparable periods in 2025.

Manufactured Product

Three Months Ended
June 30

 

Six Months Ended
June 30

($ per tonne, except as otherwise noted)

2026

 

2025

 

2026

 

2025

Sales volumes (tonnes – thousands)

 

 

 

 

 

 

 

Ammonia

403

 

734

 

701

 

1,230

Urea and ESN®

536

 

961

 

1,284

 

1,756

Solutions, nitrates and sulfates

1,314

 

1,322

 

2,609

 

2,500

Total sales volumes

2,253

 

3,017

 

4,594

 

5,486

Net selling price

 

 

 

 

 

 

 

Ammonia

609

 

408

 

554

 

412

Urea and ESN®

620

 

509

 

559

 

477

Solutions, nitrates and sulfates

335

 

287

 

309

 

263

Average net selling price

452

 

387

 

416

 

365

Cost of goods sold

216

 

219

 

220

 

222

Gross margin

236

 

168

 

196

 

143

Depreciation and amortization

56

 

55

 

58

 

56

Gross margin excluding depreciation and amortization1

292

 

223

 

254

 

199

1 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

  • Sales volumes decreased in the second quarter of 2026, reflecting no production from the Trinidad and New Madrid facilities4, planned maintenance at Carseland and deferred customer purchases. For the first half of 2026, the impact of these factors was partially offset by higher solutions, nitrates and sulfates sales volumes driven by reliability and debottlenecking initiatives.
  • Net selling price per tonne was higher in the second quarter and first half of 2026 for all major nitrogen products due to stronger global benchmark prices. In the second quarter of 2026, net selling prices reflected the portion of sales volumes established earlier in the year, prior to the onset of geopolitical conflict in the Middle East.
  • Cost of goods sold per tonne was lower in the second quarter and first half of 2026 due to lower overall natural gas costs, partially offset by higher sulfur input costs for ammonium sulfate and turnaround costs. The lower overall natural gas cost reflects a higher proportion of production from our low-cost North American nitrogen plants compared to the same periods in 2025.

Supplemental Data

Three Months Ended
June 30

 

Six Months Ended
June 30

 

2026

 

2025

 

2026

 

2025

Sales volumes (tonnes – thousands)

 

 

 

 

 

 

 

Fertilizer

1,346

 

1,845

 

2,755

 

3,234

Industrial and feed

907

 

1,172

 

1,839

 

2,252

Production volumes (tonnes – thousands)

 

 

 

 

 

 

 

Ammonia production – total1

1,056

 

1,535

 

2,178

 

3,078

Ammonia production – adjusted1, 2

956

 

1,088

 

1,975

 

2,164

Ammonia operating rate (%)2

86

 

98

 

89

 

98

Natural gas costs (dollars per MMBtu)

 

 

 

 

 

 

 

Overall natural gas cost excluding realized derivative impact

2.10

 

3.31

 

2.72

 

3.61

Realized derivative impact3

 

 

 

Overall natural gas cost

2.10

 

3.31

 

2.72

 

3.61

1 All figures are provided on a gross production basis in thousands of product tonnes.

2 Excludes Trinidad and Joffre.

3 Includes realized derivative impacts recorded as part of cost of goods sold or other income and expenses.

4 As previously disclosed, on October 23, 2025, the Trinidad nitrogen facility completed a controlled shutdown and we ceased production at our New Madrid nitrogen upgrade facility at year-end 2025.

Phosphate

 

Three Months Ended June 30

 

Six Months Ended June 30

($ millions, except as otherwise noted)

2026

 

 

2025

% Change

 

2026

 

 

2025

% Change

Net sales

468

 

396

 

18

 

953

 

756

 

26

Cost of goods sold

493

 

363

 

36

 

982

 

724

 

36

Gross margin

(25)

 

33

 

n/m

 

(29)

 

32

 

n/m

Adjusted EBITDA1

23

 

92

 

(75)

 

80

 

153

 

(48)

1 See Note 2 to the interim financial statements.

  • Phosphate adjusted EBITDA decreased in the second quarter and first half of 2026 due to higher sulfur input costs, partially offset by higher global benchmarks and sales volumes compared to the same periods of 2025.

Manufactured Product

Three Months Ended
June 30

 

Six Months Ended
June 30

($ per tonne, except as otherwise noted)

2026

 

2025

 

2026

 

2025

Sales volumes (tonnes – thousands)

 

 

 

 

 

 

 

Fertilizer

409

 

374

 

877

 

706

Industrial and feed

181

 

169

 

371

 

337

Total sales volumes

590

 

543

 

1,248

 

1,043

Net selling price

 

 

 

 

 

 

 

Fertilizer

719

 

666

 

692

 

661

Industrial and feed

919

 

821

 

901

 

819

Average net selling price

781

 

714

 

754

 

712

Cost of goods sold

812

 

646

 

766

 

672

Gross margin

(31)

 

68

 

(12)

 

40

Depreciation and amortization

117

 

125

 

113

 

134

Gross margin excluding depreciation and amortization1

86

 

193

 

101

 

174

1 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

  • Sales volumes were higher in the second quarter and the first half of 2026 due to higher production volumes from reliability improvements compared to the first half of 2025.
  • Net selling price per tonne increased in the second quarter and first half of 2026 due to stronger global benchmark prices.
  • Cost of goods sold per tonne increased in the second quarter and first half of 2026 primarily due to higher sulfur input costs.

Supplemental Data

Three Months Ended
June 30

 

Six Months Ended
June 30

 

2026

 

2025

 

2026

 

2025

Production volumes (P2O5 tonnes – thousands)

319

 

333

 

656

 

615

P2O5 operating rate (%)

75

 

79

 

78

 

73

 

Corporate and Others and Eliminations

 

Three Months Ended June 30

 

Six Months Ended June 30

($ millions, except as otherwise noted)

2026

 

 

20251, 2

 

% Change

 

2026

 

 

20251, 2

 

% Change

Corporate and Others

 

 

 

 

 

 

 

 

 

 

 

Gross margin2

 

4

 

n/m

 

14

 

18

 

(22)

Selling recovery

 

(1)

 

n/m

 

(3)

 

(4)

 

(25)

General and administrative expenses

100

 

95

 

5

 

211

 

194

 

9

Share-based compensation (recovery) expense

(41)

 

49

 

n/m

 

75

 

91

 

(18)

Foreign exchange loss, net of related derivatives

13

 

22

 

(41)

 

18

 

29

 

(38)

Other expenses

87

 

46

 

89

 

97

 

64

 

52

Adjusted EBITDA2

(89)

 

(102)

 

(13)

 

(173)

 

(180)

 

(4)

Eliminations

 

 

 

 

 

 

 

 

 

 

 

Gross margin

80

 

56

 

43

 

45

 

26

 

73

Adjusted EBITDA2

72

 

52

 

38

 

36

 

24

 

50

1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

2 See Note 2 to the interim financial statements.

  • Share-based compensation (recovery) expense was a recovery in the second quarter and a lower expense in the first half of 2026 due to a decrease in the fair value of our share-based awards. The fair value of our share-based awards takes into consideration several factors, such as our share price movement, our performance relative to our peer group and our return on invested capital.
  • Other expenses increased in the second quarter and first half of 2026 due to higher restructuring costs associated with portfolio optimization initiatives.



Finance Costs, Income Taxes and Other Comprehensive (Loss) Income

 

Three Months Ended June 30

 

Six Months Ended June 30

($ millions, except as otherwise noted)

2026

 

2025

 

% Change

 

2026

 

2025

 

% Change

Finance costs

173

 

155

 

12

 

349

 

334

 

4

Income taxes

 

 

 

 

 

 

 

 

 

 

 

Income tax expense

382

 

398

 

(4)

 

427

 

426

 

Actual effective tax rate including discrete items (%)

24

 

24

 

 

24

 

25

 

(4)

Other comprehensive (loss) income

(30)

 

184

 

n/m

 

36

 

209

 

(83)

 
  • Other comprehensive (loss) income is primarily driven by changes in the currency of our foreign operations. There was a loss in the second quarter and lower income in the first half of 2026 due to lower appreciation of the Australian and Brazilian currencies and depreciation of the Canadian currency, relative to the US dollar, compared to the same periods in 2025.



Liquidity and Capital Resources

Sources and uses of liquidity

We continued to manage our capital in accordance with our current capital allocation strategy. We believe that our internally generated cash flow, supplemented by available borrowings under new or existing financing sources, if necessary, will be sufficient to meet our anticipated capital expenditures, planned growth and development activities, and other cash requirements for the foreseeable future. Refer to the “Capital Structure and Management” section for details on our existing long-term debt and credit facilities.

Sources and uses of cash

 

Three Months Ended June 30

 

Six Months Ended June 30

($ millions, except as otherwise noted)

2026

 

2025

 

% Change

 

2026

 

2025

 

% Change

Cash provided by operating activities

2,484

 

2,538

 

(2)

 

1,633

 

1,456

 

12

Cash used in investing activities

(505)

 

(495)

 

2

 

(992)

 

(738)

 

34

Cash used in financing activities

(1,822)

 

(1,572)

 

16

 

(396)

 

(207)

 

91

Cash used for dividends and share repurchases1

(439)

 

(373)

 

18

 

(848)

 

(786)

 

8

1 This is a supplementary financial measure. See the “Other Financial Measures” section.

Cash provided by operating activities

  • Decreased in the second quarter of 2026 as higher global fertilizer benchmarks were more than offset by lower fertilizer volumes and increased sulfur costs.
  • Increased in the first half of 2026 due to increased global fertilizer benchmarks, higher Retail earnings and record Potash sales volumes.

Cash used in investing activities

  • Increased in the second quarter and first half of 2026, primarily due to the absence of proceeds from the sale of our investment in Sinofert Holdings Limited recognized in the comparable period. In the first half of 2026 capital expenditures increased due to the timing of turnaround activities in Nitrogen as well as an increase in cash used on business acquisitions.

Cash used in financing activities

  • Increased in the second quarter and first half of 2026 due to higher commercial paper repayments, partially offset by the issuance of $1.0 billion in senior notes in the second quarter of 2026 with no comparable issuance in the second quarter of 2025. In addition, we repaid senior notes maturing in the second quarter of 2025 with no comparable repayment in the second quarter of 2026.

Cash used for dividends and share repurchases

  • Increased in the second quarter and first half of 2026 due to higher share repurchases.
 

Financial Condition Review

The following is a comparison of balance sheet categories that are considered material:

 

As at

 

 

 

 

($ millions, except as otherwise noted)

June 30, 2026

 

 

December 31, 2025

 

 

$ Change

 

 

% Change

Assets

 

 

 

 

 

 

 

Cash and cash equivalents

921

 

701

 

220

 

31

Receivables

8,687

 

5,675

 

3,012

 

53

Inventories

6,164

 

6,977

 

(813)

 

(12)

Prepaid expenses and other current assets

395

 

1,396

 

(1,001)

 

(72)

Property, plant and equipment

22,672

 

22,747

 

(75)

 

Liabilities and Shareholders' Equity

 

 

 

 

 

 

 

Short-term debt

527

 

873

 

(346)

 

(40)

Trade, other payables and accrued liabilities

9,296

 

9,309

 

(13)

 

Long-term debt, including current portion

10,861

 

9,863

 

998

 

10

Share capital

13,446

 

13,519

 

(73)

 

(1)

Retained earnings

12,694

 

12,076

 

618

 

5

 
  • Explanations for changes in Cash and cash equivalents are in the “Liquidity and Capital Resources - Sources and uses of cash” section.
  • Receivables increased primarily due to the seasonality of Retail sales and a strategic extension of credit terms to our Retail customers.
  • Inventories decreased due to the seasonality of our Retail segment. Our North American inventory levels generally increase at year-end, peak in the first quarter of the year in preparation for the planting and application seasons, and are drawn down in the succeeding quarters.
  • Prepaid expenses and other current assets decreased due to Retail taking delivery of prepaid inventories during the planting and application season in North America.
  • Short-term debt decreased due to repayments of, and lower draws on, our credit facilities due to the issuance of $1.0 billion of senior notes.
  • Trade, other payables and accrued liabilities decreased due to lower customer prepayments in North America as Retail customers took delivery of prepaid sales, as well as settlement of our Retail supplier financing arrangements in 2026 that were entered into in the fourth quarter of 2025. This was partially offset by higher income tax payable as our tax provision exceeded payments.
  • Long-term debt, including current portion, increased due to the issuance of $1.0 billion of senior notes in the second quarter of 2026, the net proceeds of which were used to pay short-term debt.



Capital Structure and Management

Principal debt instruments

As part of the normal course of business, we closely monitor our liquidity position. We use a combination of cash generated from operations and short-term and long-term debt to finance our operations. We continually evaluate various financing arrangements and may seek to engage in transactions from time to time when market and other conditions are favorable. We were in compliance with our debt covenants and did not have any changes to our credit ratings for the six months ended June 30, 2026.

Capital structure (debt and equity)

($ millions)

June 30, 2026

 

December 31, 2025

Short-term debt

527

 

873

Current portion of long-term debt

1,434

 

513

Current portion of lease liabilities

366

 

346

Long-term debt

9,427

 

9,350

Lease liabilities

974

 

937

Shareholders' equity

25,938

 

25,365

 

Commercial paper, credit facilities and other debt

We have a total facility limit of approximately $7,310 million comprised of several credit facilities available in the jurisdictions where we operate. In North America, we have a commercial paper program, which is limited to the undrawn amount under our $4,500 million unsecured revolving term credit facility and excess cash invested in highly liquid securities.

As at June 30, 2026, we utilized $540 million of our total facility limit, which includes $419 million of commercial paper outstanding. During the first half of 2026, we extended the maturity of our accounts receivable purchase facility from March 6, 2026 to March 31, 2028 and entered into a $69 million uncommitted revolving demand facility.

As at June 30, 2026, $231 million in letters of credit were outstanding and committed, with $258 million of remaining credit available under our letter of credit facilities.

Our long-term debt consists primarily of notes and debentures. See the “Capital Structure and Management” section of our 2025 Annual Report for information on balances, rates and maturities for our notes and debentures. During the first half of 2026, we issued $500 million of 4.850 percent senior notes due May 29, 2031 and $500 million of 5.350 percent senior notes due May 29, 2036. See Note 6 to the interim financial statements.

Outstanding share data

 

As at August 4, 2026

Common shares

477,210,074 

Options to purchase common shares

1,890,151 

 

For more information on our capital management, see Note 4 to the annual financial statements in our 2025 Annual Report.



Quarterly Results

($ millions, except as otherwise noted)

Q2 2026

 

Q1 2026

Q4 2025

Q3 2025

Q2 2025

Q1 2025

Q4 2024

Q3 2024

Sales

10,812

 

6,046

 

5,340

 

6,007

 

10,438

 

5,100

 

5,079

 

5,348

Net earnings

1,222

 

139

 

580

 

469

 

1,229

 

19

 

118

 

25

Net earnings attributable to equity holders of Nutrien

1,214

 

131

 

571

 

464

 

1,221

 

11

 

113

 

18

Net earnings per share attributable to equity holders of Nutrien

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

2.53

 

0.27

 

1.18

 

0.96

 

2.51

 

0.02

 

0.23

 

0.04

Diluted

2.53

 

0.27

 

1.18

 

0.96

 

2.50

 

0.02

 

0.23

 

0.04

 

Our quarterly earnings are significantly affected by the seasonality of our business, fertilizer benchmark prices, global demand-supply conditions, grower affordability and weather. See Note 2 to the interim financial statements.

Accounting Policies and New IFRS Standards

Significant accounting policies are disclosed in our 2025 Annual Report and have been consistently applied for the six months ended June 30, 2026, except as described below.

Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments

Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments, were adopted effective January 1, 2026, the required adoption date. The impact was not material. On initial adoption, there was an adjustment of $(13) million to opening cash and cash equivalents as at January 1, 2026, which has been reflected in the condensed consolidated statement of cash flows for the six months ended June 30, 2026.



Critical Accounting Estimates

The preparation of financial statements in accordance with IFRS requires management to make estimates and judgments that affect reported assets, liabilities, revenues and expenses. We have discussed the development, selection and application of our key accounting policies, and the critical accounting estimates and assumptions they involve, with the Audit Committee of the Board.

Our critical accounting estimates are discussed on pages 64 to 65 of our 2025 Annual Report. There were no material changes to our critical accounting estimates for the three months ended June 30, 2026.



Controls and Procedures

Management is responsible for establishing and maintaining adequate internal control over financial reporting (“ICFR”), as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended, and National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings. ICFR is designed to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with IFRS. Any system of ICFR, no matter how well designed, has inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

There has been no change in our ICFR during the three months ended June 30, 2026, that has materially affected, or is reasonably likely to materially affect, our ICFR.



Forward-Looking Statements

Certain statements and other information included in this document, including within the “Market Outlook and Guidance” section, constitute “forward-looking information” or “forward-looking statements” (collectively, “forward-looking statements”) under applicable securities laws and within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 (such statements are often accompanied by words such as “anticipate”, “forecast”, “expect”, “believe”, “may”, “will”, “should”, “estimate”, “project”, “intend” or other similar words). All statements in this document, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to: Nutrien's business strategies, plans, prospects and opportunities; Nutrien's 2026 full-year guidance, including expectations regarding Retail adjusted EBITDA, Potash sales volumes, Nitrogen sales volumes, Phosphate sales volumes, depreciation and amortization, finance costs, effective tax rate on adjusted net earnings and capital expenditures, including the assumptions and expectations stated therein; expectations regarding the review of strategic alternatives for our Phosphate business, Trinidad Nitrogen facility and Brazilian Retail business and associated outcomes and the anticipated timing thereof; expectations regarding structural growth in our downstream business; expectations regarding our capital allocation approach and strategies, including our intentions with respect to our strategic actions and the expected timing thereof; our expectations regarding Nutrien's strategic priorities and our ability to advance and achieve such strategic priorities in 2026 and beyond; expectations regarding various performance targets in 2026 and beyond and our ability to achieve such targets; capital spending expectations for 2026 and beyond; expectations regarding performance of our operating segments in 2026 and beyond; the expectation that internally generated cash flow, supplemented by available borrowings, if necessary, will be sufficient to meet our anticipated capital expenditures, planned growth and development activities, and other cash requirements; expectations regarding payment of dividends and share repurchases; our operating segment market outlooks and our expectations for market conditions and fundamentals, and the anticipated supply and demand for our products and services, crop input demand, expected market, industry and growing conditions with respect to crop nutrient application rates, planted acres, farmer crop investment, crop mix and the need to replenish soil nutrient levels, weather conditions, input costs, production volumes and expenses, shipments, natural gas costs and availability, consumption, prices, operating rates, the impact of seasonality, import and export volumes, tariffs, trade or export restrictions, economic sanctions and restrictions, geopolitical disruptions, including the ongoing conflict in the Middle East, inventories, crop development, and natural gas curtailments; the negotiation of sales contracts; acquisitions and divestitures and the anticipated benefits thereof, including timing of the completion of, and expected proceeds from, pending or announced dispositions of non-core assets; and expectations in connection with our ability to generate free cash flow, enhance earnings quality, and deliver long-term returns to shareholders.

These forward-looking statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from such forward-looking statements. As such, undue reliance should not be placed on these forward-looking statements.

All of the forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions referred to below and elsewhere in this document. Although we believe that these assumptions are reasonable, having regard to our experience and our perception of historical trends, this list is not exhaustive of the factors that may affect any of the forward-looking statements and the reader should not place undue reliance on these assumptions and such forward-looking statements. Current conditions, economic and otherwise, render assumptions, although reasonable when made, subject to greater uncertainty.

The additional key assumptions that have been made in relation to the operation of our business as currently planned and our ability to achieve our business objectives include, among other things, assumptions with respect to: our ability to successfully implement our business strategies, growth and capital allocation investments and initiatives; that we will conduct our operations and achieve results of operations as anticipated; growth in crop nutrient sales volumes and gross margins; our ability to successfully complete, integrate and realize the anticipated benefits of our already completed and future acquisitions and divestitures, and that we will be able to implement our standards, controls, procedures and policies in respect of any acquired businesses and realize the expected synergies on the anticipated timeline or at all; increased proprietary products gross margin; successful execution of the review of strategic alternatives for our Phosphate business, Trinidad Nitrogen facility and Brazilian Retail business, within the anticipated timing and parameters, and realization of the expected benefits therefrom; continued reliability improvements; that future business, regulatory and industry conditions will be within the parameters expected by us, including with respect to prices, expenses, margins, operating rates, demand, supply, product availability, shipments, consumption, weather conditions, supplier agreements, product distribution agreements, inventory levels, exports, tariffs, including general or retaliatory tariffs, trade restrictions, international trade arrangements, government support, crop development and cost of labor and interest, exchange and effective tax rates; global economic conditions and the accuracy of our market outlook expectations for 2026 and in the future; the reliability and accuracy of third-party weather and climate forecasts, including forecasts regarding El Niño/La Niña conditions, underlying our crop production and crop price expectations; assumptions related to our assessment of recoverable amount estimates of our assets; our intention to complete share repurchases under our normal course issuer bid programs, the funding of such share repurchases, existing and future market conditions, including with respect to the price of our common shares, capital allocation priorities and compliance with respect to applicable limitations under securities laws and regulations and stock exchange policies and assumptions related to our ability to fund our dividends at the current level; our expectations regarding the impacts, direct and indirect, of certain geopolitical conflicts, including the ongoing conflict in the Middle East, on, among other things, global supply and demand, including for crop nutrients, energy and commodity prices, global interest rates, supply chains and the global macroeconomic environment, including inflation and volatility in oil prices; the adequacy of our cash generated from operations and our ability to access our credit facilities or capital markets for additional sources of financing; our ability to identify suitable candidates for acquisitions and divestitures and negotiate acceptable terms; the availability of investment opportunities that align with our strategic priorities and growth strategy; our ability to maintain investment grade ratings and achieve our performance targets; and our ability to successfully negotiate sales and other contracts and our ability to successfully implement new initiatives and programs.

Events or circumstances that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: general global economic, market and business conditions; failure to achieve expected results of our business strategy, capital allocation initiatives, results of operations or targets; failure to complete announced and future strategic and asset optimization initiatives, acquisitions or divestitures at all or on the expected terms and within the expected timeline; seasonality of our business; climate change and weather conditions, including impacts from regional flooding and/or drought conditions; crop planted acreage, yield and prices; the supply and demand and price levels for our products; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy (including general or retaliatory tariffs, trade restrictions, or other changes to international trade arrangements) and regulatory investigations; current and future litigation proceedings, investigations and other contingencies; the results of our review of strategic alternatives for our Phosphate business, Trinidad Nitrogen facility and Brazilian Retail business, including the process and the timing thereof, and whether the review will result in Nutrien undertaking a transaction, including the terms and timing relating thereto, the completion thereof and the benefits to be realized therefrom; the effects of current and future multinational trade agreements or other developments affecting the level of trade or export restrictions; government ownership requirements, changes in environmental, tax, antitrust and other laws or regulations and the interpretation thereof; political or military risks, including civil unrest, actions by armed groups or conflict and malicious acts, including terrorism and industrial espionage; our ability to access sufficient, cost-effective and timely transportation, distribution and storage of products (including potential rail transportation and port disruptions due to labor strikes and/or work stoppages or other similar actions); the occurrence of a major environmental or safety incident or becoming subject to legal or regulatory proceedings; innovation and cybersecurity risks related to our systems, including our costs of addressing or mitigating such risks; counterparty and sovereign risk; delays in completion of turnarounds at our major facilities or challenges related to our major facilities that are out of our control; interruptions of or constraints in availability of key inputs, including natural gas and sulfur; any significant impairment of the carrying amount of certain assets; the risk that rising interest rates and/or deteriorated business operating results may result in the further impairment of assets or goodwill attributed to certain of our cash generating units; risks related to reputational loss; certain complications that may arise in our mining processes; the ability to attract, engage and retain skilled employees and strikes or other forms of work stoppages; geopolitical conflicts, including the ongoing conflict in the Middle East, and their potential impact on, among other things, global market conditions and supply and demand, including for crop nutrients, energy and commodity prices, interest rates, supply chains and the global economy generally; our ability to execute on our strategies related to environmental, social and governance matters, and achieve related expectations, targets and commitments, including risks associated with disclosure thereof; and other risk factors detailed from time to time in Nutrien reports filed with the Canadian securities regulators and the SEC.

The purpose of our Retail adjusted EBITDA, depreciation and amortization, finance costs, effective tax rate and capital expenditures guidance ranges are to assist readers in understanding our expected and targeted financial results, and this information may not be appropriate for other purposes.

The forward-looking statements in this document are made as of the date hereof and Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this document as a result of new information or future events, except as may be required under applicable Canadian securities legislation or applicable US federal securities laws.



Terms and Definitions

For the definitions of certain financial and non-financial terms used in this document, as well as a list of abbreviated company names and sources, see the “Terms and definitions” section of our 2025 Annual Report. All references to per share amounts pertain to diluted net earnings (loss) per share, “n/m” indicates information that is not meaningful, and all financial amounts are stated in millions of US dollars, unless otherwise noted.



About Nutrien

Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve farmers. Our vision is to be the leading global agricultural solutions provider, delivering superior shareholder value through safe and sustainable operations. To achieve this vision, our strategy is anchored in three priorities: simplify and focus, operational excellence and a disciplined and intentional approach to capital allocation. This strategy is designed to create low-risk, structural free cash flow growth by leveraging our core competencies and to deliver reliable, growing cash returns to shareholders.

More information about Nutrien can be found at www.nutrien.com.

Selected financial data for download can be found in our data tool at https://www.nutrien.com/investors/interactive-data-tool

Such data is not incorporated by reference herein.

Nutrien will host a Conference Call on Thursday, August 6, 2026 at 10:00 a.m. Eastern Time.

Telephone conference dial-in numbers:

  • From Canada and the US: 1-800-990-2777
  • International: 1-416-855-9085
  • Conference ID: 57930. Please dial in 15 minutes prior to ensure you are placed on the call in a timely manner.

Live Audio Webcast: Visit https://www.nutrien.com/news/events/2026-q2-earnings-conference-call



Non-GAAP Financial Measures

We use both IFRS measures and certain non-GAAP financial measures to assess performance. Non-GAAP financial measures are financial measures disclosed by the Company that: (a) depict historical or expected future financial performance, financial position or cash flow of the Company; (b) with respect to their composition, exclude amounts that are included in, or include amounts that are excluded from, the composition of the most directly comparable financial measure disclosed in the primary financial statements of the Company; (c) are not disclosed in the financial statements of the Company; and (d) are not a ratio, fraction, percentage or similar representation. Non-GAAP ratios are financial measures disclosed by the Company that are in the form of a ratio, fraction, percentage or similar representation that has a non-GAAP financial measure as one or more of its components, and that are not disclosed in the financial statements of the Company.

These non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under IFRS and, therefore, are unlikely to be comparable to similar financial measures presented by other companies. Management believes these non-GAAP financial measures and non-GAAP ratios provide transparent and useful supplemental information to help investors evaluate our financial performance, financial condition and liquidity using the same measures as management. These non-GAAP financial measures and non-GAAP ratios should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with IFRS.

The following section outlines our non-GAAP financial measures and non-GAAP ratios, their compositions, and why management uses each measure. It also includes reconciliations to the most directly comparable IFRS measures. Except as otherwise described herein, our non-GAAP financial measures and non-GAAP ratios are calculated on a consistent basis from period to period and are adjusted for specific items in each period, as applicable. As additional non-recurring or unusual items arise in the future, we generally exclude these items in our calculations.

Adjusted EBITDA (Consolidated)

Most directly comparable IFRS financial measure: Net earnings (loss).

Definition: Adjusted EBITDA is calculated as net earnings (loss) before finance costs, income taxes, depreciation and amortization, share-based compensation and foreign exchange gain/loss (net of related derivatives). We also adjust this measure for the following other income and expenses that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on sale of certain businesses and investments, asset retirement obligations (“ARO”) and accrued environmental costs (“ERL”) related to our non-operating sites, and loss related to financial instruments in Argentina.

Why we use the measure and why it is useful to investors: It is not impacted by long-term investment and financing decisions, but rather focuses on the performance of our day-to-day operations. It provides a measure of our ability to service debt and to meet other payment obligations and as a component of employee remuneration calculations.

 

Three Months Ended
June 30

 

Six Months Ended
June 30

($ millions)

2026

 

2025

 

2026

 

2025

Net earnings

1,222

 

1,229

 

1,361

 

1,248

Finance costs

173

 

155

 

349

 

334

Income tax expense

382

 

398

 

427

 

426

Depreciation and amortization

604

 

614

 

1,210

 

1,185

EBITDA1

2,381

 

2,396

 

3,347

 

3,193

Adjustments:

 

 

 

 

 

 

 

Share-based compensation (recovery) expense

(41)

 

49

 

75

 

91

Foreign exchange loss, net of related derivatives

13

 

22

 

18

 

29

ARO/ERL related expenses (income) for non-operating sites

11

 

(2)

 

(17)

 

3

Restructuring costs

66

 

21

 

82

 

22

Impairment of assets recorded in other income and expenses

 

 

30

 

Adjusted EBITDA

2,430

 

2,486

 

3,535

 

3,338

1 EBITDA is calculated as net earnings before finance costs, income taxes, and depreciation and amortization.

 

Adjusted Net Earnings and Adjusted Net Earnings Per Share

Most directly comparable IFRS financial measure: Net earnings (loss) and diluted net earnings (loss) per share.

Definition: Adjusted net earnings and related per share information are calculated as net earnings (loss) before share-based compensation and foreign exchange gain/loss (net of related derivatives), net of tax. We also adjust this measure for the following other income and expenses (net of tax) that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on sale of certain businesses and investments, gain or loss on early extinguishment of debt or on settlement of derivatives due to discontinuance of hedge accounting, asset retirement obligations and accrued environmental costs related to our non-operating sites, loss related to financial instruments in Argentina, change in recognition of tax losses and deductible temporary differences related to impairments and certain changes to tax declarations. We generally apply the annual forecasted effective tax rate to specific adjustments during the year, and at year-end, we apply the actual effective tax rate.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations and is used as a component of employee remuneration calculations.

 

Three Months Ended
June 30, 2026

 

Six Months Ended
June 30, 2026

 

 

 

 

 

 

 

Per

 

 

 

 

 

 

 

 

Per

 

Increases

 

 

 

 

 

Diluted

 

 

Increases

 

 

 

 

 

Diluted

($ millions, except as otherwise noted)

(Decreases)

 

 

Post-Tax

 

 

Share

 

 

(Decreases)

 

 

Post-Tax

 

 

Share

Net earnings attributable to equity holders of Nutrien

 

 

1,214

 

2.53

 

 

 

1,345

 

2.80

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

Share-based compensation (recovery) expense

(41)

 

(32)

 

(0.07)

 

75

 

56

 

0.12

Foreign exchange loss, net of related derivatives

13

 

8

 

0.02

 

18

 

18

 

0.03

ARO/ERL related expenses (income) for non-operating sites

11

 

9

 

0.02

 

(17)

 

(13)

 

(0.03)

Restructuring costs

66

 

52

 

0.11

 

82

 

68

 

0.14

Impairment of assets recorded in other income and expenses

 

 

 

30

 

22

 

0.05

Sub-total adjustments

49

 

37

 

0.08

 

188

 

151

 

0.31

Adjusted net earnings

 

 

1,251

 

2.61

 

 

 

1,496

 

3.11

 

 

Three Months Ended
June 30, 2025

 

Six Months Ended
June 30, 2025

 

 

 

 

 

 

 

Per

 

 

 

 

 

 

 

 

Per

 

Increases

 

 

 

 

 

Diluted

 

 

Increases

 

 

 

 

 

Diluted

($ millions, except as otherwise noted)

(Decreases)

 

 

Post-Tax

 

 

Share

 

 

(Decreases)

 

 

Post-Tax

 

 

Share

Net earnings attributable to equity holders of Nutrien

 

 

1,221

 

2.50

 

 

 

1,232

 

2.52

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

Share-based compensation expense

49

 

37

 

0.08

 

91

 

68

 

0.14

Foreign exchange loss, net of related derivatives

22

 

17

 

0.04

 

29

 

23

 

0.05

ARO/ERL related (income) expenses for non-operating sites

(2)

 

(1)

 

 

3

 

3

 

Restructuring costs

21

 

17

 

0.03

 

22

 

18

 

0.04

Sub-total adjustments

90

 

70

 

0.15

 

145

 

112

 

0.23

Adjusted net earnings

 

 

1,291

 

2.65

 

 

 

1,344

 

2.75

 
 

Effective Tax Rate on Adjusted Net Earnings

Effective tax rate on adjusted net earnings guidance is a forward-looking non-GAAP financial measure as it includes adjusted net earnings, which is a non-GAAP financial measure. It is provided to assist readers in understanding our expected financial results. Effective tax rate on adjusted net earnings guidance excludes certain items that management is aware of that permit management to focus on the performance of our operations (see the Adjusted Net Earnings and Adjusted Net Earnings Per Share section for items generally adjusted). We do not provide a reconciliation of this forward-looking measure to the most directly comparable financial measures calculated and presented in accordance with IFRS because a meaningful or accurate calculation of reconciling items and the information is not available without unreasonable effort due to unknown variables, including the timing and amount of certain reconciling items, and the uncertainty related to future results. These unknown variables may include unpredictable transactions of significant value that may be inherently difficult to determine without unreasonable efforts. The probable significance of such unavailable information, which could be material to future results, cannot be addressed.

Gross Margin Excluding Depreciation and Amortization Per Tonne – Manufactured Product

Most directly comparable IFRS financial measure: Gross margin.

Definition: Gross margin per tonne less depreciation and amortization per tonne for manufactured products. Reconciliations are provided in the “Segment Results” section.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations, which excludes the effects of items that primarily reflect the impact of long-term investment and financing decisions.

Potash Controllable Cash Cost of Product Manufactured (“COPM”) Per Tonne

Most directly comparable IFRS financial measure: Cost of goods sold (“COGS”) for the Potash segment.

Definition: Total Potash COGS excluding depreciation and amortization expense included in COPM, royalties, natural gas costs and carbon taxes, change in inventory, and other adjustments, divided by potash production tonnes.

Why we use the measure and why it is useful to investors: To assess operational performance. Potash controllable cash COPM excludes the effects of production from other periods and the impacts of our long-term investment decisions, supporting a focus on the performance of our day-to-day operations. Potash controllable cash COPM also excludes royalties and natural gas costs and carbon taxes, which management does not consider controllable, as they are primarily driven by regulatory and market conditions.

 

Three Months Ended
June 30

 

Six Months Ended
June 30

($ millions, except as otherwise noted)

2026

 

2025

 

2026

 

2025

Total COGS – Potash

446

 

440

 

868

 

820

Change in inventory

1

 

(58)

 

9

 

(51)

Other adjustments1

(4)

 

(8)

 

(9)

 

(21)

COPM

443

 

374

 

868

 

748

Depreciation and amortization in COPM

(183)

 

(147)

 

(354)

 

(292)

Royalties in COPM

(27)

 

(23)

 

(53)

 

(42)

Natural gas costs and carbon taxes in COPM

(12)

 

(10)

 

(25)

 

(22)

Controllable cash COPM

221

 

194

 

436

 

392

Production volumes (tonnes – thousands)

3,996

 

3,531

 

7,656

 

6,820

Potash controllable cash COPM per tonne

55

 

55

 

57

 

57

1 Other adjustments include unallocated production overhead that is recognized as part of cost of goods sold but is not included in the measurement of inventory and changes in inventory balances.

 

Retail Cash Operating Coverage Ratio

Definition: Retail selling, general and administrative, and other expenses (income), excluding depreciation and amortization expense, divided by Retail gross margin excluding depreciation and amortization expense in cost of goods sold, for the last four rolling quarters.

Why we use the measure and why it is useful to investors: To understand the costs and underlying economics of our Retail operations and to assess our Retail operating performance and ability to generate cash flow.

 

Rolling Four Quarters Ended June 30, 2026

($ millions, except as otherwise noted)

Q3 2025

 

Q4 2025

 

Q1 2026

 

Q2 2026

 

Total

Selling expenses

792

 

811

 

798

 

998

 

3,399

General and administrative expenses

44

 

40

 

44

 

55

 

183

Other expenses

40

 

4

 

36

 

45

 

125

Operating expenses

876

 

855

 

878

 

1,098

 

3,707

Depreciation and amortization in operating expenses

(179)

 

(184)

 

(179)

 

(177)

 

(719)

Operating expenses excluding depreciation and amortization

697

 

671

 

699

 

921

 

2,988

 

 

 

 

 

 

 

 

 

 

Gross margin

922

 

977

 

800

 

2,046

 

4,745

Depreciation and amortization in cost of goods sold

5

 

5

 

5

 

6

 

21

Gross margin excluding depreciation and amortization

927

 

982

 

805

 

2,052

 

4,766

Cash operating coverage ratio (%)

 

 

 

 

 

 

 

 

63

 

 

 

 

 

 

 

 

 

 

 

Rolling Four Quarters Ended December 31, 2025

($ millions, except as otherwise noted)

Q1 2025

 

Q2 2025

 

Q3 2025

 

Q4 2025

 

Total

Selling expenses

755

 

948

 

792

 

811

 

3,306

General and administrative expenses

44

 

44

 

44

 

40

 

172

Other expenses

25

 

54

 

40

 

4

 

123

Operating expenses

824

 

1,046

 

876

 

855

 

3,601

Depreciation and amortization in operating expenses

(179)

 

(172)

 

(179)

 

(184)

 

(714)

Operating expenses excluding depreciation and amortization

645

 

874

 

697

 

671

 

2,887

 

 

 

 

 

 

 

 

 

 

Gross margin

686

 

2,018

 

922

 

977

 

4,603

Depreciation and amortization in cost of goods sold

5

 

5

 

5

 

5

 

20

Gross margin excluding depreciation and amortization

691

 

2,023

 

927

 

982

 

4,623

Cash operating coverage ratio (%)

 

 

 

 

 

 

 

 

62

 
 

Retail Average Working Capital to Sales

Definition: Retail average working capital divided by Retail sales for the last four rolling quarters.

Why we use the measure and why it is useful to investors: To evaluate operational efficiency. A lower or higher percentage represents increased or decreased efficiency, respectively.

 

Rolling Four Quarters Ended June 30, 2026

($ millions, except as otherwise noted)

Q3 2025

 

Q4 2025

 

Q1 2026

 

Q2 2026

 

Average/Total

Current assets

10,823

 

11,185

 

12,558

 

12,063

 

 

Current liabilities

(5,348)

 

(8,275)

 

(7,799)

 

(7,930)

 

 

Working capital

5,475

 

2,910

 

4,759

 

4,133

 

4,319

 

 

 

 

 

 

 

 

 

 

Sales

3,427

 

3,144

 

3,640

 

8,270

 

18,481

Average working capital to sales (%)

 

 

 

 

 

 

 

 

23

 

 

 

 

 

 

 

 

 

 

 

Rolling Four Quarters Ended December 31, 2025

($ millions, except as otherwise noted)

Q1 2025

 

Q2 2025

 

Q3 2025

 

Q4 2025

 

Average/Total

Current assets

11,510

 

11,442

 

10,823

 

11,185

 

 

Current liabilities

(7,561)

 

(8,051)

 

(5,348)

 

(8,275)

 

 

Working capital

3,949

 

3,391

 

5,475

 

2,910

 

3,931

 

 

 

 

 

 

 

 

 

 

Sales

3,090

 

7,959

 

3,427

 

3,144

 

17,620

Average working capital to sales (%)

 

 

 

 

 

 

 

 

22

 
 

Other Financial Measures

Selected Additional Financial Data

Nutrien Financial Aging

As at June 30, 2026

As at

December 31, 2025

($ millions)

Current

 

<31 Days

past due

 

31–90 Days

past due

 

>90 Days

past due

 

Gross receivables

 

Allowance1

 

 

Net receivables2

 

Net

receivables

North America

3,686

157

60

226

4,129

(66)

4,063

2,332

International

916

70

23

36

1,045

(7)

1,038

774

Nutrien Financial receivables

4,602

227

83

262

5,174

(73)

5,101

3,106

1 Bad debt expense on the above receivables for the six months ended June 30, 2026 was $32 million, in the Retail segment.

2 In 2026, we assume a debt-to-equity ratio of 9:1 (2025 – 9:1) in funding Nutrien Financial receivables, based on the underlying credit quality of the assets.

Nutrien Financial Net Receivables

Rolling Four Quarters Ended June 30, 2026

($ millions, except as otherwise noted)

Q3 2025

 

 

Q4 2025

 

 

Q1 2026

 

 

Q2 2026

 

 

Average/Total

Average Nutrien Financial net receivables

4,452

 

3,106

 

3,035

 

5,101

 

3,924

 
 

Supplementary Financial Measures

Supplementary financial measures are financial measures disclosed by the Company that (a) are, or are intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of the Company, (b) are not disclosed in the financial statements of the Company, (c) are not non-GAAP financial measures, and (d) are not non-GAAP ratios.

The following section provides an explanation of the composition of those supplementary financial measures, if not previously provided.

Sustaining capital expenditures: Represents capital expenditures that are required to sustain operations at existing levels and include major repairs and maintenance and plant turnarounds.

Investing capital expenditures: Represents capital expenditures related to significant expansions of current operations or to create cost savings (synergies). Investing capital expenditures exclude capital outlays for business acquisitions and equity-accounted investees.

Mine development and pre-stripping capital expenditures: Represents capital expenditures that are required for activities to open new areas underground and/or develop a mine or ore body to allow for future production mining and activities required to prepare and/or access the ore, i.e., removal of an overburden that allows access to the ore.

Cash used for dividends and share repurchases: Calculated as dividends paid to Nutrien’s shareholders plus repurchase of common shares as reflected in the unaudited condensed consolidated statements of cash flows. This measure is useful as it represents return of cash to shareholders.



Condensed Consolidated Financial Statements

Unaudited
Condensed Consolidated Statements of Earnings

 

 

Three Months Ended

 

Six Months Ended

 

 

June 30

 

June 30

($ millions, except as otherwise noted)

Note

2026

 

2025

 

2026

 

2025

Sales

2, 8

10,812

 

10,438

 

16,858

 

15,538

Freight, transportation and distribution

 

203

 

240

 

447

 

466

Cost of goods sold

 

7,358

 

7,023

 

11,514

 

10,577

Gross Margin

 

3,251

 

3,175

 

4,897

 

4,495

Selling expenses

 

1,001

 

951

 

1,800

 

1,708

General and administrative expenses

 

169

 

148

 

333

 

300

Provincial mining taxes

 

110

 

97

 

200

 

165

Share-based compensation (recovery) expense

 

(41)

 

49

 

75

 

91

Foreign exchange loss, net of related derivatives

 

13

 

22

 

16

 

29

Other expenses

3

222

 

126

 

336

 

194

Earnings Before Finance Costs and Income Taxes

1,777

 

1,782

 

2,137

 

2,008

Finance costs

 

173

 

155

 

349

 

334

Earnings Before Income Taxes

 

1,604

 

1,627

 

1,788

 

1,674

Income tax expense

4

382

 

398

 

427

 

426

Net Earnings

 

1,222

 

1,229

 

1,361

 

1,248

Attributable to

 

 

 

 

 

 

 

 

Equity holders of Nutrien

 

1,214

 

1,221

 

1,345

 

1,232

Non-controlling interest

 

8

 

8

 

16

 

16

Net Earnings

 

1,222

 

1,229

 

1,361

 

1,248

 

 

 

 

 

 

 

 

 

Net Earnings Per Share Attributable to Equity Holders of Nutrien ("EPS")

Basic

 

2.53

 

2.51

 

2.80

 

2.52

Diluted

 

2.53

 

2.50

 

2.80

 

2.52

Weighted average shares outstanding for basic EPS

 

479,600,000

 

487,396,000

 

480,426,000

 

488,391,000

Weighted average shares outstanding for diluted EPS

 

479,824,000

 

487,598,000

 

480,725,000

 

488,563,000

 

 

 

 

 

 

 

 

 

(See Notes to the Condensed Consolidated Financial Statements)

 

Condensed Consolidated Statements of Comprehensive Income

 

Three Months Ended

 

Six Months Ended

 

June 30

 

June 30

($ millions, net of related income taxes)

2026

 

2025

 

2026

 

2025

Net Earnings

1,222

 

1,229

 

1,361

 

1,248

Other comprehensive (loss) income

 

 

 

 

 

 

 

Items that will not be reclassified to net earnings:

 

 

 

 

 

 

 

Net fair value loss on investments

(10)

 

 

(10)

 

(18)

Items that have been or may be subsequently reclassified to net earnings:

 

 

 

 

 

 

 

(Loss) gain on currency translation of foreign operations

(11)

 

162

 

61

 

201

Other

(9)

 

22

 

(15)

 

26

Other Comprehensive (Loss) Income

(30)

 

184

 

36

 

209

Comprehensive Income

1,192

 

1,413

 

1,397

 

1,457

Attributable to

 

 

 

 

 

 

 

Equity holders of Nutrien

1,184

 

1,404

 

1,380

 

1,440

Non-controlling interest

8

 

9

 

17

 

17

Comprehensive Income

1,192

 

1,413

 

1,397

 

1,457

 

 

 

 

 

 

 

 

(See Notes to the Condensed Consolidated Financial Statements)

 

Condensed Consolidated Statements of Cash Flows

 

 

Three Months Ended

 

Six Months Ended

 

 

June 30

 

June 30

($ millions)

Note

2026

 

2025

 

2026

 

2025

Operating Activities

 

 

 

 

 

 

 

 

Net earnings

 

1,222

 

1,229

 

1,361

 

1,248

Adjustments for:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

604

 

614

 

1,210

 

1,185

Share-based compensation (recovery) expense

 

(41)

 

49

 

75

 

91

(Recovery of) provision for deferred income tax

 

(17)

 

(48)

 

24

 

32

Net (undistributed) distributed earnings of equity-accounted investees

 

(1)

 

90

 

(2)

 

85

Long-term income tax receivables and payables

 

1

 

54

 

(14)

 

16

Other long-term assets, liabilities and miscellaneous

 

70

 

(37)

 

97

 

(32)

Cash from operations before working capital changes

 

1,838

 

1,951

 

2,751

 

2,625

Changes in non-cash operating working capital:

 

 

 

 

 

 

 

 

Receivables

 

(2,385)

 

(2,462)

 

(2,915)

 

(2,605)

Inventories and prepaid expenses and other current assets

 

2,909

 

2,894

 

1,918

 

1,620

Trade, other payables and accrued liabilities

 

122

 

155

 

(121)

 

(184)

Cash Provided by Operating Activities

 

2,484

 

2,538

 

1,633

 

1,456

Investing Activities

 

 

 

 

 

 

 

 

Capital expenditures1

 

(491)

 

(424)

 

(816)

 

(724)

Business acquisitions, net of cash acquired

 

10

 

 

(40)

 

(11)

Purchase of investments, held within three months, net

 

(33)

 

(53)

 

(41)

 

(69)

Purchase of investments

 

(1)

 

(91)

 

(1)

 

(93)

Proceeds from sale of investments

 

 

93

 

 

276

Net changes in non-cash working capital

 

16

 

10

 

(78)

 

(78)

Other

 

(6)

 

(30)

 

(16)

 

(39)

Cash Used in Investing Activities

 

(505)

 

(495)

 

(992)

 

(738)

Financing Activities

 

 

 

 

 

 

 

 

(Repayment of) proceeds from debt, maturing within three months, net

 

(2,239)

 

(578)

 

(318)

 

334

Proceeds from debt

6

1,000

 

 

1,000

 

998

Repayment of debt

 

(36)

 

(531)

 

(45)

 

(535)

Repayment of principal portion of lease liabilities

 

(108)

 

(106)

 

(208)

 

(216)

Dividends paid to Nutrien's shareholders

7

(266)

 

(268)

 

(528)

 

(533)

Repurchase of common shares

7

(173)

 

(105)

 

(320)

 

(253)

Issuance of common shares

 

2

 

26

 

47

 

29

Other

 

(2)

 

(10)

 

(24)

 

(31)

Cash Used in Financing Activities

 

(1,822)

 

(1,572)

 

(396)

 

(207)

Effect of Exchange Rate Changes on Cash and Cash Equivalents

 

(13)

 

21

 

(12)

 

23

Increase in Cash and Cash Equivalents

 

144

 

492

 

233

 

534

January 1, 2026 opening balance prior to restatement for amendments to IFRS 9

9

 

 

701

 

Adjustment on initial application of amendments to IFRS 9 on January 1, 2026

9

 

 

(13)

 

Cash and Cash Equivalents – Beginning of Period

 

777

 

895

 

688

 

853

Cash and Cash Equivalents – End of Period

 

921

 

1,387

 

921

 

1,387

Cash and cash equivalents is composed of:

 

 

 

 

 

 

 

 

Cash

 

726

 

1,228

 

726

 

1,228

Short-term investments

 

195

 

159

 

195

 

159

 

 

921

 

1,387

 

921

 

1,387

Supplemental Cash Flows Information

 

 

 

 

 

 

 

 

Interest paid

 

192

 

220

 

340

 

352

Income taxes paid (received)

 

87

 

(19)

 

124

 

(12)

Total cash outflow for leases

 

159

 

139

 

296

 

289

1 Includes additions to property, plant and equipment, and intangible assets for the three months ended June 30, 2026 of $469 million and $22 million (2025 – $398 million and $26 million), respectively, and for the six months ended June 30, 2026 of $768 million and $48 million (2025 – $677 million and $47 million), respectively.

(See Notes to the Condensed Consolidated Financial Statements)
 

Condensed Consolidated Statements of Changes in Shareholders’ Equity

 

 

 

 

 

 

 

Accumulated other comprehensive

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(loss) income ("AOCI")

 

 

 

 

 

 

 

($ millions, inclusive of related tax, except as otherwise noted)

Number of
common
shares

 

Share
capital

 

Contributed
surplus

 

(Loss) gain
on currency
translation
of foreign
operations

 

Other

 

Total
AOCI

 

Retained
earnings

 

Equity
holders
of
Nutrien

 

Non-
controlling
interest

 

Total
equity

Balance – December 31, 2024

491,025,446

 

13,748

 

68

 

(537)

 

22

 

(515)

 

11,106

 

24,407

 

35

 

24,442

Net earnings

 

 

 

 

 

 

1,232

 

1,232

 

16

 

1,248

Other comprehensive income

 

 

 

200

 

8

 

208

 

 

208

 

1

 

209

Shares repurchased for cancellation (Note 7)

(4,741,786)

 

(133)

 

(10)

 

 

 

 

(114)

 

(257)

 

 

(257)

Dividends declared1

 

 

 

 

 

 

(533)

 

(533)

 

 

(533)

Non-controlling interest transactions

 

 

 

 

 

 

 

 

(21)

 

(21)

Effect of share-based compensation including

issuance of common shares

581,799

 

35

 

(3)

 

 

 

 

 

32

 

 

32

Transfer of net gain on sale of investment

 

 

 

 

(27)

 

(27)

 

27

 

 

 

Transfer of net loss on cash flow hedges

 

 

 

 

1

 

1

 

 

1

 

 

1

Other

 

 

 

(2)

 

 

(2)

 

1

 

(1)

 

 

(1)

Balance – June 30, 2025

486,865,459

 

13,650

 

55

 

(339)

 

4

 

(335)

 

11,719

 

25,089

 

31

 

25,120

Balance – December 31, 2025

481,962,233

 

13,519

 

57

 

(329)

 

 

(329)

 

12,076

 

25,323

 

42

 

25,365

Net earnings

 

 

 

 

 

 

1,345

 

1,345

 

16

 

1,361

Other comprehensive income (loss)

 

 

 

60

 

(25)

 

35

 

 

35

 

1

 

36

Shares repurchased for cancellation (Note 7)

(4,576,390)

 

(128)

 

 

 

 

 

(199)

 

(327)

 

 

(327)

Dividends declared1

 

 

 

 

 

 

(529)

 

(529)

 

 

(529)

Non-controlling interest transactions

 

 

 

 

 

 

 

 

(23)

 

(23)

Effect of share-based compensation including

issuance of common shares

906,954

 

55

 

(6)

 

 

 

 

 

49

 

 

49

Transfer of net loss on cash flow hedges

 

 

 

 

5

 

5

 

 

5

 

 

5

Other

 

 

 

 

 

 

1

 

1

 

 

1

Balance – June 30, 2026

478,292,797

 

13,446

 

51

 

(269)

 

(20)

 

(289)

 

12,694

 

25,902

 

36

 

25,938

1 During the six months ended June 30, 2026, we declared dividends of $1.10 per share (2025 - $1.09 per share).

 

(See Notes to the Condensed Consolidated Financial Statements)

 
 

Condensed Consolidated Balance Sheets

 

 

 

 

As at

 

 

As at June 30

 

December 31

($ millions)

Note

2026

 

2025

 

2025

Assets

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash and cash equivalents

 

921

 

1,387

 

701

Receivables

8

8,687

 

8,086

 

5,675

Inventories

 

6,164

 

5,576

 

6,977

Prepaid expenses and other current assets

 

395

 

566

 

1,396

 

 

16,167

 

15,615

 

14,749

Non-current assets

 

 

 

 

 

 

Property, plant and equipment

 

22,672

 

22,496

 

22,747

Goodwill

 

12,174

 

12,121

 

12,136

Intangible assets

 

1,565

 

1,745

 

1,667

Investments

 

137

 

407

 

144

Other assets

 

840

 

871

 

858

Total Assets

 

53,555

 

53,255

 

52,301

Liabilities

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Short-term debt

6

527

 

1,882

 

873

Current portion of long-term debt

6

1,434

 

538

 

513

Current portion of lease liabilities

 

366

 

363

 

346

Trade, other payables and accrued liabilities

8

9,296

 

8,991

 

9,309

 

 

11,623

 

11,774

 

11,041

Non-current liabilities

 

 

 

 

 

 

Long-term debt

6

9,427

 

9,867

 

9,350

Lease liabilities

 

974

 

988

 

937

Deferred income tax liabilities

 

3,687

 

3,512

 

3,666

Pension and other post-retirement benefit liabilities

 

214

 

232

 

221

Asset retirement obligations and accrued environmental costs

 

1,447

 

1,536

 

1,468

Other non-current liabilities

 

245

 

226

 

253

Total Liabilities

 

27,617

 

28,135

 

26,936

Shareholders’ Equity

 

 

 

 

 

 

Share capital

7

13,446

 

13,650

 

13,519

Contributed surplus

 

51

 

55

 

57

Accumulated other comprehensive loss

 

(289)

 

(335)

 

(329)

Retained earnings

 

12,694

 

11,719

 

12,076

Equity holders of Nutrien

 

25,902

 

25,089

 

25,323

Non-controlling interest

 

36

 

31

 

42

Total Shareholders’ Equity

 

25,938

 

25,120

 

25,365

Total Liabilities and Shareholders’ Equity

 

53,555

 

53,255

 

52,301

 

 

 

 

 

 

 

(See Notes to the Condensed Consolidated Financial Statements)

 

Notes to the Condensed Consolidated Financial Statements
As at and for the Three and Six Months Ended June 30, 2026

Note 1 Basis of presentation

Nutrien Ltd. (collectively with its subsidiaries, “Nutrien”, “we”, “us”, “our” or “the Company”) is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of farmers.

These unaudited interim condensed consolidated financial statements (“interim financial statements”) are based on International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board and have been prepared in accordance with IAS 34, “Interim Financial Reporting”. The accounting policies and methods of computation used in preparing these interim financial statements are materially consistent with those used in the preparation of our 2025 annual audited consolidated financial statements with the exception of the amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments, which were adopted effective January 1, 2026 (refer to Note 9). These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual audited consolidated financial statements and should be read in conjunction with our 2025 annual audited consolidated financial statements. These interim financial statements are presented in millions of US dollars, unless otherwise indicated, which is the functional currency of Nutrien and the majority of its subsidiaries.

Certain immaterial 2025 figures have been reclassified in Note 2 Segment information.

In management’s opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year.

These interim financial statements were authorized by the Audit Committee of the Board of Directors for issue on August 5, 2026.

Note 2 Segment information

We have four reportable operating segments: Retail, Potash, Nitrogen and Phosphate. Our downstream Retail segment distributes crop nutrients, crop protection products, seed and merchandise, and provides agronomic application services and solutions, including the services offered through Nutrien Financial. Retail also manufactures and distributes proprietary products and provides services directly to farmers through a network of retail locations in North America, Australia and South America. Our upstream Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each segment produces and are supported by midstream activities, which include the global sales, freight, transportation and distribution of our products, which are reported within these segments, respectively. Potash freight, transportation and distribution reported costs only apply to our North American potash sales volumes. Sales reported under our Corporate and Others segment relates to our non-core businesses. EBITDA presented in the succeeding tables is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

Seasonality in our business results from increased demand for products during planting season. Crop input sales are generally higher in the spring and fall application seasons. Crop input inventories are normally accumulated leading up to each application season. Our cash collections generally occur after the application season is complete, while customer prepayments made to us are typically concentrated in December and January and inventory prepayments paid to our suppliers are typically concentrated in the period from November to January. Feed and industrial sales are more evenly distributed throughout the year.

In the fourth quarter of 2025, the Chief Operating Decision Maker (“CODM”) reassessed our product groupings and determined that the performance of our Purchase for Resale business should be evaluated as part of the Corporate and Others segment. It had previously been presented in our Nitrogen segment. The Purchase for Resale business focuses primarily on sales to international customers. Purchased product that remains in upstream is primarily purchases of inventory to satisfy sales contracts that we cannot fulfill with our manufactured products. The CODM concluded this change was appropriate based on the nature and strategic alignment of purchase for resale activities. Comparative amounts for the Corporate and Others and Nitrogen segments were reclassified. As a result of the reclassification, the Corporate and Others segment reflected the following increases and the Nitrogen segment reflected the corresponding decreases for the three and six months ended June 30, 2025.

 

 

Three Months Ended

 

Six Months Ended

($ millions)

June 30, 2025

 

June 30, 2025

Sales

73

 

143

Gross Margin

3

 

7

EBITDA

2

 

5

 

 

 

Three Months Ended June 30, 2026

 

 

Downstream

 

Upstream and Midstream

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate

 

 

 

 

($ millions)

Retail

 

Potash

 

Nitrogen

 

Phosphate

 

and Others

 

Eliminations

 

Consolidated

Sales

– third party

8,270

 

1,055

 

959

 

441

 

87

 

 

10,812

 

– intersegment

 

80

 

314

 

84

 

 

(478)

 

Sales

– total

8,270

 

1,135

 

1,273

 

525

 

87

 

(478)

 

10,812

Freight, transportation and distribution1

 

82

 

119

 

57

 

(1)

 

(54)

 

203

Net sales

8,270

 

1,053

 

1,154

 

468

 

88

 

(424)

 

10,609

Cost of goods sold

6,224

 

446

 

611

 

493

 

88

 

(504)

 

7,358

Gross margin

2,046

 

607

 

543

 

(25)

 

 

80

 

3,251

Selling expenses (recovery)

998

 

2

 

6

 

2

 

 

(7)

 

1,001

General and administrative expenses

55

 

4

 

7

 

3

 

100

 

 

169

Provincial mining taxes

 

110

 

 

 

 

 

110

Share-based compensation recovery

 

 

 

 

(41)

 

 

(41)

Foreign exchange loss, net of related derivatives

 

 

 

 

13

 

 

13

Other expenses

45

 

14

 

45

 

16

 

87

 

15

 

222

Earnings (loss) before finance costs and income taxes

948

 

477

 

485

 

(46)

 

(159)

 

72

 

1,777

Depreciation and amortization

183

 

181

 

150

 

69

 

21

 

 

604

EBITDA

1,131

 

658

 

635

 

23

 

(138)

 

72

 

2,381

Share-based compensation recovery

 

 

 

 

(41)

 

 

(41)

Foreign exchange loss, net of related derivatives

 

 

 

 

13

 

 

13

ARO/ERL related expenses for non-operating sites2 (Note 3)

 

 

 

 

11

 

 

11

Restructuring costs (Note 3)

 

 

 

 

66

 

 

66

Adjusted EBITDA

1,131

 

658

 

635

 

23

 

(89)

 

72

 

2,430

1 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

2 ARO/ERL refers to asset retirement obligations and accrued environmental costs.

 

 

 

Three Months Ended June 30, 2025

 

 

Downstream

 

Upstream and Midstream

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate

 

 

 

 

($ millions)

Retail

 

Potash

 

Nitrogen1

 

Phosphate

 

and Others1

 

Eliminations

 

Consolidated

Sales

– third party

7,959

 

992

 

1,031

 

382

 

74

 

 

10,438

 

– intersegment

 

93

 

309

 

67

 

 

(469)

 

Sales

– total

7,959

 

1,085

 

1,340

 

449

 

74

 

(469)

 

10,438

Freight, transportation and distribution2

 

94

 

153

 

53

 

 

(60)

 

240

Net sales

7,959

 

991

1,187

 

396

 

74

 

(409)

 

10,198

Cost of goods sold

5,941

 

440

 

674

 

363

 

70

 

(465)

 

7,023

Gross margin

2,018

 

551

 

513

 

33

 

4

 

56

 

3,175

Selling expenses (recovery)

948

 

2

 

7

 

1

 

(1)

 

(6)

 

951

General and administrative expenses

44

 

2

 

6

 

1

 

95

 

 

148

Provincial mining taxes

 

97

 

 

 

 

 

97

Share-based compensation expense

 

 

 

 

49

 

 

49

Foreign exchange loss, net of related derivatives

 

 

 

 

22

 

 

22

Other expenses

54

 

8

 

1

 

7

 

46

 

10

 

126

Earnings (loss) before finance costs and income taxes

972

 

442

 

499

 

24

 

(207)

 

52

 

1,782

Depreciation and amortization

177

 

188

 

166

 

68

 

15

 

 

614

EBITDA

1,149

 

630

 

665

 

92

 

(192)

 

52

 

2,396

Share-based compensation expense

 

 

 

 

49

 

 

49

Foreign exchange loss, net of related derivatives

 

 

 

 

22

 

 

22

ARO/ERL related income for non-operating sites (Note 3)

 

 

 

 

(2)

 

 

(2)

Restructuring costs (Note 3)

 

 

 

 

21

 

 

21

Adjusted EBITDA

1,149

 

630

 

665

 

92

 

(102)

 

52

 

2,486

1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

2 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

 

 

 

Six Months Ended June 30, 2026

 

 

Downstream

 

Upstream and Midstream

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate

 

 

 

 

($ millions)

Retail

 

Potash

 

Nitrogen

 

Phosphate

 

and Others

 

Eliminations

 

Consolidated

Sales

– third party

11,910

 

2,021

 

1,843

 

919

 

165

 

 

16,858

 

– intersegment

 

155

 

561

 

153

 

 

(869)

 

Sales

– total

11,910

 

2,176

 

2,404

 

1,072

 

165

 

(869)

 

16,858

Freight, transportation and distribution1

 

197

 

236

 

119

 

(1)

 

(104)

 

447

Net sales

11,910

 

1,979

 

2,168

 

953

 

166

 

(765)

 

16,411

Cost of goods sold

9,064

 

868

 

1,258

 

982

 

152

 

(810)

 

11,514

Gross margin

2,846

 

1,111

 

910

 

(29)

 

14

 

45

 

4,897

Selling expenses (recovery)

1,796

 

5

 

12

 

4

 

(3)

 

(14)

 

1,800

General and administrative expenses

99

 

7

 

11

 

5

 

211

 

 

333

Provincial mining taxes

 

200

 

 

 

 

 

200

Share-based compensation expense

 

 

 

 

75

 

 

75

Foreign exchange (gain) loss, net of related derivatives

(2)

 

 

 

 

18

 

 

16

Other expenses

81

 

40

 

72

 

23

 

97

 

23

 

336

Earnings (loss) before finance costs and income taxes

872

 

859

 

815

 

(61)

 

(384)

 

36

 

2,137

Depreciation and amortization

367

 

356

 

302

 

141

 

44

 

 

1,210

EBITDA

1,239

 

1,215

 

1,117

 

80

 

(340)

 

36

 

3,347

Share-based compensation expense

 

 

 

 

75

 

 

75

Foreign exchange loss, net of related derivatives

 

 

 

 

18

 

 

18

ARO/ERL related income for non-operating sites (Note 3)

 

 

 

 

(17)

 

 

(17)

Restructuring costs (Note 3)

 

 

 

 

82

 

 

82

Impairment of assets recorded in other income and expenses (Note 3)

 

21

 

 

 

9

 

 

30

Adjusted EBITDA

1,239

 

1,236

 

1,117

 

80

 

(173)

 

36

 

3,535

1 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

 

 

 

Six Months Ended June 30, 2025

 

 

Downstream

 

Upstream and Midstream

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate

 

 

 

 

($ millions)

Retail

 

Potash

Nitrogen1

 

Phosphate

and Others1

 

Eliminations

 

Consolidated

Sales

– third party

11,049

 

1,758

 

1,853

 

720

 

158

 

 

15,538

 

– intersegment

 

188

 

491

 

134

 

 

(813)

 

Sales

– total

11,049

 

1,946

 

2,344

 

854

 

158

 

(813)

 

15,538

Freight, transportation and distribution2

 

211

 

272

 

98

 

1

 

(116)

 

466

Net sales

11,049

 

1,735

 

2,072

 

756

 

157

 

(697)

 

15,072

Cost of goods sold

8,345

 

820

 

1,272

 

724

 

139

 

(723)

 

10,577

Gross margin

2,704

 

915

 

800

 

32

 

18

 

26

 

4,495

Selling expenses (recovery)

1,703

 

5

 

14

 

3

 

(4)

 

(13)

 

1,708

General and administrative expenses

88

 

4

 

11

 

3

 

194

 

 

300

Provincial mining taxes

 

165

 

 

 

 

 

165

Share-based compensation expense

 

 

 

 

91

 

 

91

Foreign exchange loss, net of related derivatives

 

 

 

 

29

 

 

29

Other expenses

79

 

10

 

13

 

13

 

64

 

15

 

194

Earnings (loss) before finance costs and income taxes

834

 

731

 

762

 

13

 

(356)

 

24

 

2,008

Depreciation and amortization

361

 

345

 

308

 

140

 

31

 

 

1,185

EBITDA

1,195

 

1,076

 

1,070

 

153

 

(325)

 

24

 

3,193

Share-based compensation expense

 

 

 

 

91

 

 

91

Foreign exchange loss, net of related derivatives

 

 

 

 

29

 

 

29

ARO/ERL related expenses for non-operating sites (Note 3)

 

 

 

 

3

 

 

3

Restructuring costs (Note 3)

 

 

 

 

22

 

 

22

Adjusted EBITDA

1,195

 

1,076

 

1,070

 

153

 

(180)

 

24

 

3,338

1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

2 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

 

Three Months Ended

 

Six Months Ended

 

June 30

 

June 30

($ millions)

2026

 

2025

 

2026

 

2025

Retail sales by product line

 

 

 

 

 

 

 

Crop nutrients

3,541

 

3,391

 

5,024

 

4,585

Crop protection products

2,755

 

2,666

 

3,892

 

3,638

Seed

1,278

 

1,278

 

1,840

 

1,810

Services and other

308

 

286

 

483

 

432

Merchandise

291

 

238

 

514

 

427

Nutrien Financial

145

 

135

 

225

 

205

Nutrien Financial elimination1

(48)

 

(35)

 

(68)

 

(48)

 

8,270

 

7,959

 

11,910

 

11,049

Potash sales by geography

 

 

 

 

 

 

 

Manufactured product

 

 

 

 

 

 

 

North America

353

 

382

 

837

 

816

Offshore2

781

 

701

 

1,338

 

1,127

Other potash and purchased products

1

 

2

 

1

 

3

 

1,135

 

1,085

 

2,176

 

1,946

Nitrogen sales by product line

 

 

 

 

 

 

 

Manufactured product

 

 

 

 

 

 

 

Ammonia

289

 

359

 

456

 

599

Urea and ESN®

355

 

530

 

771

 

912

Solutions, nitrates and sulfates

492

 

430

 

908

 

751

Other nitrogen and purchased products3

137

 

21

 

269

 

82

 

1,273

 

1,340

 

2,404

 

2,344

Phosphate sales by product line

 

 

 

 

 

 

 

Manufactured product

 

 

 

 

 

 

 

Fertilizer

335

 

285

 

694

 

534

Industrial and feed

183

 

155

 

366

 

306

Other phosphate and purchased products

7

 

9

 

12

 

14

 

525

 

449

 

1,072

 

854

1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

2 Relates to Canpotex Limited ("Canpotex") (see Note 8) and includes provisional pricing adjustments for the three months ended June 30, 2026 of $18 million (2025 – $27 million) and the six months ended June 30, 2026 of $15 million (2025 – $58 million).

3 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

Note 3 Other expenses (income)

 

Three Months Ended

 

Six Months Ended

 

June 30

 

June 30

($ millions)

2026

 

2025

 

2026

 

2025

Restructuring costs

66

 

21

 

82

 

22

Earnings of equity-accounted investees

(4)

 

(9)

 

(6)

 

(14)

Bad debt expense

34

 

38

 

49

 

57

Project feasibility costs

24

 

26

 

42

 

41

Customer prepayment costs

19

 

19

 

38

 

37

Legal expenses

12

 

5

 

17

 

7

ARO/ERL related expenses (income) for non-operating sites

11

 

(2)

 

(17)

 

3

Impairment of assets

 

 

30

 

Other expenses

60

 

28

 

101

 

41

 

222

 

126

 

336

 

194

Note 4 Income taxes

 

Three Months Ended

 

Six Months Ended

 

June 30

 

June 30

($ millions, except as otherwise noted)

2026

 

2025

 

2026

 

2025

Actual effective tax rate on earnings (%)

23

 

23

 

24

 

24

Actual effective tax rate including discrete items (%)

24

 

24

 

24

 

25

Discrete tax adjustments that impacted the tax rate1

11

 

22

 

3

 

27

1 Discrete tax adjustments arise from specific, significant or unusual events that are recognized in the period in which the event occurs, rather than being allocated across the year through the annual effective tax rate.

Note 5 Financial instruments

Our financial instruments carrying amounts are a reasonable approximation of their fair values, except for our long-term debt, including current portion, that has a carrying value of $10,861 million and fair value of $10,400 million as at June 30, 2026. There were no transfers between levels for financial instruments measured at fair value on a recurring basis.

Note 6 Debt

On May 29, 2026, we issued $1 billion of senior notes. The senior notes are unsecured, rank equally with our existing unsecured debt, and have no sinking fund requirements prior to maturity. Each series of outstanding senior notes is redeemable and has various provisions for redemption prior to maturity, at our option, at specified prices.

($ millions, except as otherwise noted)

Rate of interest (%)

 

Maturity

 

Amount

Senior notes issued in 2026

4.850

 

May 29, 2031

 

500

Senior notes issued in 2026

5.350

 

May 29, 2036

 

500

 

 

 

 

 

1,000

During the six months ended June 30, 2026, we entered into a $69 million uncommitted revolving demand facility. As at June 30, 2026, there were no borrowings outstanding under this facility. We also extended the maturity of our accounts receivable purchase facility from March 6, 2026 to March 31, 2028.

Note 7 Share capital

Share repurchase programs

The following table summarizes our share repurchase activities during the periods indicated below:

 

Three Months Ended

 

Six Months Ended

 

June 30

 

June 30

($ millions, except as otherwise noted)

2026

 

2025

 

2026

 

2025

Number of common shares repurchased for cancellation

2,494,887

 

1,878,972

 

4,576,390

 

4,741,786

Average price per share (US dollars)

69.33

 

56.39

 

70.08

 

53.19

Total cost, inclusive of tax

179

 

108

 

327

 

257

Subsequent to June 30, 2026, as of August 4, 2026, an additional 1,238,033 common shares were repurchased for cancellation at a cost of $82 million and an average price per share of $66.98.

Dividends declared

We declared a dividend per share of $0.55 (2025 – $0.545) during the three months ended June 30, 2026, payable on July 17, 2026 to shareholders of record on June 30, 2026.

Note 8 Related party transactions

We sell potash outside Canada and the US exclusively through Canpotex. Our total revenue is recognized at the time product is loaded for shipping, at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex. The receivable outstanding from Canpotex arose from sale transactions described above. It is unsecured and bears no interest. Any credit losses held against this receivable are expected to be negligible. Canpotex sells potash to buyers, including Nutrien, in export markets pursuant to term and spot contracts at agreed-upon prices. Purchases from Canpotex for the three months ended June 30, 2026 were $58 million (2025 – $20 million) and the six months ended June 30, 2026 were $122 million (2025 – $77 million).

 

 

As at

 

 

As at

($ millions)

 

June 30, 2026

 

 

December 31, 2025

Receivables from Canpotex

 

339

 

279

Payables to Canpotex

 

100

 

63

Note 9 Accounting policies, estimates and judgments

Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments

Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments, were adopted effective January 1, 2026, the required adoption date. The amendments clarified the timing of recognition and derecognition of financial assets and financial liabilities. The adoption resulted in a change in the accounting policy relating to the timing of the derecognition of certain financial assets and financial liabilities, such that derecognition now occurs upon settlement.

The amendments were applied retrospectively without restatement of prior periods in accordance with the transitional provisions other than, on initial adoption, there was an adjustment of $(13) million to opening cash and cash equivalents as at January 1, 2026, which has been reflected in the condensed consolidated statement of cash flows for the six months ended June 30, 2026.



Contacts

For Further Information:

Investor Contact:
Jeff Holzman
Senior Vice President, Investor Relations and FP&A
(306) 933-8545 – investors@nutrien.com

Media Contact:
Simon Scott
Vice President, Global Communications
(403) 225-7213 – media@nutrien.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  272.65
-4.77 (-1.72%)
AAPL  311.00
+1.62 (0.52%)
AMD  482.05
-36.53 (-7.04%)
BAC  63.25
+0.35 (0.56%)
GOOG  360.13
-15.22 (-4.05%)
META  588.77
+0.83 (0.14%)
MSFT  487.46
-5.35 (-1.09%)
NVDA  219.22
+7.28 (3.43%)
ORCL  144.39
-1.35 (-0.93%)
TSLA  321.55
-5.80 (-1.77%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback